Baudax Bio Ownership 2024 | Who Owns Baudax Bio Now?

OverviewFinancials Chart

Institutional Ownership

0.01%

Insider Ownership

0.02%

Retail Ownership

99.97%

Institutional Holders

1.00

Baudax Bio Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	9.89%	-	32,812	32,812	100.00%	55,780,000	Mar 31, 2023
VANGUARD GROUP INC	7.51%	-	24,900	24,900	100.00%	42,330,000	Mar 31, 2023
STATE STREET CORP	3.50%	-	11,602	-7,200	-38.29%	19,723,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.47%	0.00%	1,548	1,247	414.29%	3,000	Mar 31, 2023
JPMORGAN CHASE & CO	0.46%	-	1,511	1,511	100.00%	3,000,000	Mar 31, 2023
FMR LLC	0.32%	-	1,056	1,056	100.00%	1,795,000	Mar 31, 2023
BLACKROCK INC.	0.24%	-	797	-	-	1,355,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	22	22	100.00%	35,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	4	-	-	7,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	3	-	-	5,000	Mar 31, 2023
SITTNER & NELSON, LLC	0.00%	-	1	-	-	2,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	1	-1	-50.00%	2,000	Mar 31, 2023
UBS GROUP AG	-	-	-	-3,011	-100.00%	-	Mar 31, 2023
EDMOND DE ROTHSCHILD HOLDING S.A.	-	-	-	-71	-100.00%	-	Mar 31, 2023

Baudax Bio's largest institutional shareholder is SUSQUEHANNA INTERNATIONAL GROUP, LLP, holding 9.89% of the company's total share outstanding, currently valued at $55.78M. The top 10 institutional shareholders own together 22.39% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TOWER RESEARCH CAPITAL LLC (TRC)	0.47%	0.00%	1,548	1,247	414.29%	3,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	9.89%	-	32,812	32,812	100.00%	55,780,000	Mar 31, 2023
SITTNER & NELSON, LLC	0.00%	-	1	-	-	2,000	Mar 31, 2023
STATE STREET CORP	3.50%	-	11,602	-7,200	-38.29%	19,723,000	Mar 31, 2023
VANGUARD GROUP INC	7.51%	-	24,900	24,900	100.00%	42,330,000	Mar 31, 2023
JPMORGAN CHASE & CO	0.46%	-	1,511	1,511	100.00%	3,000,000	Mar 31, 2023
FMR LLC	0.32%	-	1,056	1,056	100.00%	1,795,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	22	22	100.00%	35,000	Mar 31, 2023
BLACKROCK INC.	0.24%	-	797	-	-	1,355,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	4	-	-	7,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	3	-	-	5,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	1	-1	-50.00%	2,000	Mar 31, 2023
UBS GROUP AG	-	-	-	-3,011	-100.00%	-	Mar 31, 2023
EDMOND DE ROTHSCHILD HOLDING S.A.	-	-	-	-71	-100.00%	-	Mar 31, 2023

The largest Baudax Bio shareholder by % of total assets is TOWER RESEARCH CAPITAL LLC (TRC). The company owns 1.55K shares of Baudax Bio (BXRX), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	9.89%	-	32,812	32,812	100.00%	55,780,000	Mar 31, 2023
VANGUARD GROUP INC	7.51%	-	24,900	24,900	100.00%	42,330,000	Mar 31, 2023
JPMORGAN CHASE & CO	0.46%	-	1,511	1,511	100.00%	3,000,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.47%	0.00%	1,548	1,247	414.29%	3,000	Mar 31, 2023
FMR LLC	0.32%	-	1,056	1,056	100.00%	1,795,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	22	22	100.00%	35,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	3	-	-	5,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	4	-	-	7,000	Mar 31, 2023
BLACKROCK INC.	0.24%	-	797	-	-	1,355,000	Mar 31, 2023
SITTNER & NELSON, LLC	0.00%	-	1	-	-	2,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	1	-1	-50.00%	2,000	Mar 31, 2023
EDMOND DE ROTHSCHILD HOLDING S.A.	-	-	-	-71	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-3,011	-100.00%	-	Mar 31, 2023
STATE STREET CORP	3.50%	-	11,602	-7,200	-38.29%	19,723,000	Mar 31, 2023

As of Mar 31 2023, Baudax Bio's largest institutional buyer is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company purchased 32.81K stocks of BXRX, valued at $55.78M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
STATE STREET CORP	3.50%	-	11,602	-7,200	-38.29%	19,723,000	Mar 31, 2023
UBS GROUP AG	-	-	-	-3,011	-100.00%	-	Mar 31, 2023
EDMOND DE ROTHSCHILD HOLDING S.A.	-	-	-	-71	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	0.00%	-	1	-1	-50.00%	2,000	Mar 31, 2023
SITTNER & NELSON, LLC	0.00%	-	1	-	-	2,000	Mar 31, 2023
BLACKROCK INC.	0.24%	-	797	-	-	1,355,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	4	-	-	7,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	3	-	-	5,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	22	22	100.00%	35,000	Mar 31, 2023
FMR LLC	0.32%	-	1,056	1,056	100.00%	1,795,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.47%	0.00%	1,548	1,247	414.29%	3,000	Mar 31, 2023
JPMORGAN CHASE & CO	0.46%	-	1,511	1,511	100.00%	3,000,000	Mar 31, 2023
VANGUARD GROUP INC	7.51%	-	24,900	24,900	100.00%	42,330,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	9.89%	-	32,812	32,812	100.00%	55,780,000	Mar 31, 2023

As of Mar 31 2023, Baudax Bio's biggest institutional seller is STATE STREET CORP. The company sold -7.20K shares of BXRX, valued at $19.72M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	9.89%	-	32,812	32,812	100.00%	55,780,000	Mar 31, 2023
VANGUARD GROUP INC	7.51%	-	24,900	24,900	100.00%	42,330,000	Mar 31, 2023
JPMORGAN CHASE & CO	0.46%	-	1,511	1,511	100.00%	3,000,000	Mar 31, 2023
FMR LLC	0.32%	-	1,056	1,056	100.00%	1,795,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	22	22	100.00%	35,000	Mar 31, 2023

Baudax Bio's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 32.81K shares, valued at $55.78M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	-	-	-	-3,011	-100.00%	-	Mar 31, 2023
EDMOND DE ROTHSCHILD HOLDING S.A.	-	-	-	-71	-100.00%	-	Mar 31, 2023

Baudax Bio's largest sold out institutional shareholder by shares sold is UBS GROUP AG, sold -3.01K shares, valued at -, as of undefined.

Baudax Bio Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
OBERWEIS FUNDS	0.13%	133,160	-	-	Mar 31, 2024
AMG FUNDS III	0.01%	33,658	-	-	Mar 28, 2024
FIDELITY CONCORD STREET TRUST	0.00%	64,352	-	-	Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC	0.00%	6,248	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	58,320	-	-	Mar 31, 2024
Meeder Funds	0.00%	647	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	48,300	-	-	Mar 31, 2024
PRUDENTIAL INVESTMENT PORTFOLIOS, INC.	0.00%	1,040	-	-	Mar 28, 2024
NORTHERN FUNDS	0.00%	5,890	-	-	Mar 28, 2024
ALLSPRING MASTER TRUST	0.00%	1,009	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	1,552	-	-	Feb 29, 2024
PENN SERIES FUNDS INC	0.00%	200	-	-	Mar 28, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	4,631	-	-	Mar 31, 2024
MASSMUTUAL SELECT FUNDS	0.00%	1,155	-	-	Dec 31, 2023
T. Rowe Price Index Trust, Inc.	0.00%	23	-	-	Feb 29, 2024
Blackstone Alternative Investment Funds	0.00%	43	-	-	Mar 31, 2023
EQ ADVISORS TRUST	0.00%	417	-	-	Mar 31, 2024

Baudax Bio's largest mutual fund holder by % of total assets is "OBERWEIS FUNDS", owning 133.16K shares, compromising 0.13% of its total assets.

Baudax Bio Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 22	1	-93.33%
30 Sep, 22	15	-
30 Jun, 22	15	-6.25%
31 Mar, 22	16	-

As of 31 Dec 22, 1 institutions are holding Baudax Bio's shares, representing a decrease of -93.33% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 22	71	-100.00%
30 Sep, 22	1,432,997	12.24%
30 Jun, 22	1,276,758	2.68%
31 Mar, 22	1,243,391	-

Baudax Bio (BXRX) has 71.00 shares outstanding as of 31 Dec 22, down -100.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 22	0.01%	0.04%
30 Sep, 22	4.78%	26.37%
30 Jun, 22	4.26%	24.78%
31 Mar, 22	4.14%	-

As of 31 Dec 22, Baudax Bio is held by 0.01% institutional shareholders, representing a 0.04% growth compared to 30 Sep 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 22	-	-100.00%
30 Sep, 22	10	25.00%
30 Jun, 22	8	-50.00%
31 Mar, 22	16	-

- institutional shareholders have increased their position in BXRX stock as of 31 Dec 22 compared to 10 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 22	1	-66.67%
30 Sep, 22	3	-
30 Jun, 22	3	-
31 Mar, 22	-	-

1 institutional shareholders have reduced their position in BXRX stock as of 31 Dec 22 compared to 3 in the previous quarter (a -66.67% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 22	1	-93.33%	71	-100.00%	0.01%	0.04%	-	-100.00%	1	-66.67%
30 Sep, 22	15	-	1,432,997	12.24%	4.78%	26.37%	10	25.00%	3	-
30 Jun, 22	15	-6.25%	1,276,758	2.68%	4.26%	24.78%	8	-50.00%	3	-
31 Mar, 22	16	-	1,243,391	-	4.14%	-	16	-	-	-

Baudax Bio Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Dec 19, 2022	HENWOOD GERALDINE	officer	President and CEO	P-Purchase	Buy	1,200	$2.55	$3.06K	2,427

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Dec 19, 2022	HENWOOD GERALDINE	officer	President and CEO	P-Purchase	Buy	1,200	$2.55	$3.06K	2,427

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 13, 2023	Kim Yong Chan	director	-		Sell	-	-	-	202,260
Jul 13, 2023	Kim Yong Chan	director	-		Sell	4,520,066	-	-	-
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	-	-	-	171
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	-	-	-	67
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	-	-	-	25
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	313	$45.50	$14.24K	-
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	257	$221.55	$56.94K	-
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	162	$39.20	$6.35K	-
Dec 23, 2021	HENWOOD GERALDINE	director, officer	President and CEO	F-InKind	Sell	18,636	$0.31	$5.78K	336,716
Dec 14, 2021	HENWOOD GERALDINE	director, officer	President and CEO	F-InKind	Sell	9,155	$0.35	$3.20K	355,352

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Oct 11, 2023	McAndrew Natalie	officer	-		Buy	-	-	-	-
Jul 13, 2023	Kim Yong Chan	director	-		Sell	-	-	-	202,260
Jul 13, 2023	Kim Yong Chan	director	-		Sell	4,520,066	-	-	-
Dec 19, 2022	HENWOOD GERALDINE	officer	President and CEO	P-Purchase	Buy	1,200	$2.55	$3.06K	2,427
Jun 17, 2022	Ashton William	director		A-Award	Buy	39,473	-	-	42,534
Jun 17, 2022	Baskies Arnold M	director		A-Award	Buy	39,473	-	-	41,942
Jun 17, 2022	CHURCHILL WINSTON J	director		A-Award	Buy	39,473	-	-	46,820
Jun 17, 2022	Drechsler Andrew T	director		A-Award	Buy	39,473	-	-	41,656
Jun 17, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary	A-Award	Buy	15,467	-	-	15,738
Jun 17, 2022	HENWOOD GERALDINE	officer	President and CEO	A-Award	Buy	39,473	-	-	49,093
Jun 17, 2022	Weisman Wayne	director		A-Award	Buy	39,473	-	-	42,900
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	-	-	-	171
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	-	-	-	67
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	-	-	-	25
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	313	$45.50	$14.24K	-
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	257	$221.55	$56.94K	-
Apr 26, 2022	Dilmore Jillian	officer	Corporate Controller/Secretary		Sell	162	$39.20	$6.35K	-
Dec 23, 2021	HENWOOD GERALDINE	director, officer	President and CEO	A-Award	Buy	821,168	$1.70	$1.40M	821,168
Dec 23, 2021	HENWOOD GERALDINE	director, officer	President and CEO	F-InKind	Sell	18,636	$0.31	$5.78K	336,716
Dec 14, 2021	HENWOOD GERALDINE	director, officer	President and CEO	F-InKind	Sell	9,155	$0.35	$3.20K	355,352

The last insider sell of Baudax Bio's stock was made by Kim Yong Chan on Jul 13 2023, selling - shares at - per share (valued at -). The last insider buy of BXRX was made by HENWOOD GERALDINE on Dec 19 2022, buying 1,200 shares at $2.55 per share (worth $3.06K).

Baudax Bio Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	-	-	-
Q3 2023	-	2	-
Q4 2022	1	-	-
Q2 2022	7	6	116.67%
Q4 2021	1	2	50.00%
Q3 2021	3	-	-
Q2 2021	17	-	-
Q1 2021	10	1	1000.00%
Q4 2020	1	4	25.00%
Q3 2020	2	-	-
Q2 2020	8	-	-
Q1 2020	6	2	300.00%
Q4 2019	11	2	550.00%

0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Baudax Bio's insiders, as of Q4 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	-	-	-
Q3 2023	-	-	-
Q4 2022	1	-	-
Q2 2022	-	-	-
Q4 2021	-	-	-
Q3 2021	3	-	-
Q2 2021	5	-	-
Q1 2021	1	-	-
Q4 2020	1	-	-
Q3 2020	-	-	-
Q2 2020	-	-	-
Q1 2020	4	-	-
Q4 2019	-	-	-

As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Baudax Bio's stocks.

Baudax Bio Peer Ownership

Ticker	Company
BDRX	Biodexa Pharmaceuticals Plc
CFRX	ContraFect Corporation
CNSP	CNS Pharmaceuticals, Inc.
ENSC	Ensysce Biosciences, Inc.
NEXI	NexImmune, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
YS	LakeShore Biopharma Co., Ltd
HILS	Tharimmune, Inc.
DRMA	Dermata Therapeutics, Inc.
VRAX	Virax Biolabs Group Limited
ALLR	Allarity Therapeutics, Inc.
CYTO	Altamira Therapeutics Ltd.
NRBO	NeuroBo Pharmaceuticals, Inc.
WINT	Windtree Therapeutics, Inc.
PALI	Palisade Bio, Inc.

BXRX Ownership FAQ

Who Owns Baudax Bio?

Baudax Bio is owned by institutional shareholders (0.01%), insiders (0.02%), and public (99.97%). The largest institutional shareholder of Baudax Bio is SUSQUEHANNA INTERNATIONAL GROUP, LLP (9.89% of total shares) and the top mutual fund owner is OBERWEIS FUNDS (0.13% of total shares).

Who are the major institutional shareholders of Baudax Bio?

Baudax Bio's major institutional shareholders are SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD GROUP INC, STATE STREET CORP, TOWER RESEARCH CAPITAL LLC (TRC), and JPMORGAN CHASE & CO. The top five shareholders own together 21.82% of the company's share outstanding.

How many Baudax Bio shareholders are there?

As of Dec 2022, there are 1 institutional shareholders of Baudax Bio.

What percentage of Baudax Bio is owned by SUSQUEHANNA INTERNATIONAL GROUP, LLP?

SUSQUEHANNA INTERNATIONAL GROUP, LLP owns 32.81K shares of Baudax Bio, representing 9.89% of the company's total shares outstanding, valued at $55.78M (as of Mar 2023).

What percentage of Baudax Bio is owned by VANGUARD GROUP INC?

As of Mar 2023, VANGUARD GROUP INC holds 24.9K shares of Baudax Bio (BXRX), compromising 7.51% of the company, valued at $42.33M.

What percentage of Baudax Bio is owned by STATE STREET CORP?

STATE STREET CORP is the third largest holder of Baudax Bio. The company owns 11.6K of the company's shares outstanding (worth $19.72M).